Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
It also supports immune function, red blood cell formation, and the conversion of stored glycogen into usable glucose for energy, which becomes especially relevant during the caloric deficit that semaglutide naturally creates
there are no trials, studies, or research to citeyet
MONDAY, June 8, 2026 (HealthDay News) -- Glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with reduced risks for thromboembolic events, emergency department use, and mortality among adults with obesity and autoimmune diseases (AIDs), according to a study published online June 6 in the Journal of the American Heart Association to coincide with the annual meeting of the American Diabetes Association, held from June 5 to 8 in New Orleans.Hao Dai, Ph.D., from the Indiana University School of Medicine in Indianapolis, and colleagues conducted a retrospective cohort study, which emulated a target trial using 2014 to 2024 electronic health record data to examine the association between GLP-1 RA use and major adverse cardiovascular and thromboembolic event risk among adults with obesity and AID
This persistent inflammatory microenvironment exerts multifaceted effects on PCOS pathogenesis: on one hand, it disrupts normal follicular development, promotes ovarian fibrosis and granulosa cell apoptosis, and exacerbates ovulatory dysfunction and the formation of polycystic ovarian morphology
The study comes from a single large health system in Ohio and Florida, which limits how broadly the findings can be applied across different demographics and care settings
Kang N, Ma J, Zhou X, Fan X, Shang X, Huang Y
